Published in Ann Pharmacother on October 01, 1999
Epigenetic regulation of CD8(+) T-lymphocyte mediated suppression of HIV-1 replication. Virology (2010) 0.90
Safe Treatment of Seizures in the Setting of HIV/AIDS. Curr Treat Options Neurol (2013) 0.86
Comment: potential risk of valproic acid therapy in patients who are HIV-positive. Ann Pharmacother (2000) 0.76
[Clinical features, diagnosis and treatment of HIV-induced neuropsychiatric disorders]. Wien Med Wochenschr (2006) 0.75
Clear lens phacoemulsification for correction of high myopia. J Cataract Refract Surg (2001) 1.52
Efficacy of wrists overnight compression (HT 7 point) on insomniacs: possible role of melatonin? Minerva Med (2008) 0.91
Physical activity as a possible aggravating factor for athletes with varicocele: impact on the semen profile. Hum Reprod (2001) 0.88
Salivary steroids at rest and after a training load in young male athletes: relationship with chronological age and pubertal development. Int J Sports Med (2006) 0.85
Does normal thyroid gland by ultrasonography match with normal serum thyroid hormones and negative thyroid antibodies? Exp Clin Endocrinol Diabetes (2009) 0.83
The long-acting phosphodiesterase inhibitor tadalafil does not influence athletes' VO2max, aerobic, and anaerobic thresholds in normoxia. Int J Sports Med (2007) 0.82
Acute amino acids supplementation enhances pituitary responsiveness in athletes. Med Sci Sports Exerc (1999) 0.82
Do non-steroidal anti-inflammatory drugs influence the steroid hormone milieu in male athletes? Int J Sports Med (2007) 0.81
Aspirin inhibits androgen response to chorionic gonadotropin in humans. Am J Physiol (1999) 0.81
Medullary thyroid nodules by measurement of calcitonin (Ct) in aspiration needle washout in patients with multinodular goiter and moderately elevated serum Ct. Exp Clin Endocrinol Diabetes (2012) 0.81
High sensitive thyroglobulin assay on thyroxine therapy: can it avoid stimulation test in low and high risk differentiated thyroid carcinoma patients? Horm Metab Res (2013) 0.81
Macular translocation with 360 degrees retinotomy for management of retinal pigment epithelial tear: long-term results. Br J Ophthalmol (2010) 0.81
Measuring calcitonin in washout of the needle in patients undergoing fine needle aspiration with suspicious medullary thyroid cancer. Diagn Cytopathol (2011) 0.81
Acetylsalicylic acid inhibits the pituitary response to exercise-related stress in humans. Med Sci Sports Exerc (2001) 0.79
Androgenic-anabolic steroids abuse in males. J Endocrinol Invest (2005) 0.77
Physical stress and qualitative gonadotropin secretion: LH biological activity at rest and after exercise in trained and untrained men. Int J Sports Med (2002) 0.77
Cortisol, dehydroepiandrosterone sulphate and dehydroepiandrosterone sulphate/cortisol ratio responses to physical stress in males are influenced by pubertal development. J Endocrinol Invest (2006) 0.77
Acute effect of physical exercise on serum insulin-like growth factor-binding protein 2 and 3 in healthy men: role of exercise-linked growth hormone secretion. Int J Sports Med (2001) 0.77
Changes of lipocalin type prostaglandin D-synthase in the seminal plasma of subfertile man. Res Commun Mol Pathol Pharmacol (2002) 0.77
Growth hormone and insulin-like growth factor I responses to moderate submaximal acute physical exercise in man: effects of octreotide, a somatostatin analogue, administration. Int J Sports Med (1997) 0.77
Testosterone responses to standardized short-term sub-maximal and maximal endurance exercises: issues on the dynamic adaptive role of the hypothalamic-pituitary-testicular axis. J Endocrinol Invest (2014) 0.77
Heredity and pituitary response to exercise-related stress in trained men. Int J Sports Med (2003) 0.76
[Treatment of male idiopathic sterility with gonadotropin]. Minerva Endocrinol (1991) 0.76
Comment: potential risk of valproic acid therapy in patients who are HIV-positive. Ann Pharmacother (2000) 0.76
Role of seminal prostaglandins in male fertility. II. Effects of prostaglandin synthesis inhibition on spermatogenesis in man. J Endocrinol Invest (1985) 0.75
Comment: risk of drug-disease and disease-drug interactions with anticonvulsants in HIV-positive patients. Ann Pharmacother (1999) 0.75
Urinary and serum hormones profiles after testosterone enanthate administration in male hypogonadism: concerns on the detection of doping with testosterone in treated hypogonadal athletes. J Endocrinol Invest (2009) 0.75
Endocrine and metabolic aspects in male senescence. J Endocrinol Invest (1985) 0.75
[Effect of hypothalamic phospholipids in the incretory activity of the hypophysis]. Minerva Endocrinol (1986) 0.75
[Pigmentations and melanotic lesions in unusual sites]. Pathologica (1986) 0.75
[Thyroid gland involvement in acute leukemia. Ultrasonographic aspects of a case]. Radiol Med (2000) 0.75
Timing of HIV pharmacotherapy. J Am Pharm Assoc (Wash) (2001) 0.75
[Radiological aspects of pulmonary circulation in patients treated with periodic dialysis]. Radiol Med (1971) 0.75
Role of arachidonate metabolism on the in vitro release of luteinizing hormone and prolactin from the anterior pituitary gland: possible involvement of lipoxygenase pathway. Neuroendocrinology (1986) 0.75
Pharmacist intervention to control lice resistance. J Am Pharm Assoc (Wash) (1999) 0.75
Subclinical hyperthyroidism and sport eligibility: an exploratory study on cardiovascular pre-participation screening in subjects treated with levothyroxine for multinodular goiter. J Endocrinol Invest (2009) 0.75
Study shows how to measure energy use, costs in food service. Hospitals (1979) 0.75
Effects of the "vascular factor" on platelet and vascular arachidonic acid metabolism in man. Int J Clin Pharmacol Ther Toxicol (1985) 0.75
Endothelin stimulates testosterone secretion by rat Leydig cells. J Endocrinol (1993) 0.75
[Diagnostic imaging and therapeutic implications in lung infections in patients with HIV-1 infection]. Radiol Med (1997) 0.75
Gonadal function changes in healthy, aging men. J Endocrinol Invest (2002) 0.75
Aspirin inhibition of naloxone-induced luteinizing hormone secretion in man. J Clin Endocrinol Metab (1996) 0.75